Buckingham Capital Management Inc. Has $13.24 Million Stock Position in Stryker Co. (NYSE:SYK)

Buckingham Capital Management Inc. decreased its holdings in Stryker Co. (NYSE:SYK - Free Report) by 1.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 36,783 shares of the medical technology company's stock after selling 671 shares during the period. Stryker comprises 1.5% of Buckingham Capital Management Inc.'s portfolio, making the stock its 19th largest holding. Buckingham Capital Management Inc.'s holdings in Stryker were worth $13,244,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Dunhill Financial LLC grew its stake in shares of Stryker by 94.9% in the 3rd quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company's stock valued at $27,000 after buying an additional 37 shares in the last quarter. Darwin Wealth Management LLC bought a new stake in shares of Stryker in the 3rd quarter valued at approximately $36,000. Activest Wealth Management bought a new stake in shares of Stryker in the 4th quarter valued at approximately $36,000. Crews Bank & Trust bought a new stake in shares of Stryker in the 4th quarter valued at approximately $39,000. Finally, Hara Capital LLC bought a new stake in Stryker during the third quarter worth approximately $42,000. Institutional investors own 77.09% of the company's stock.

Insider Activity

In related news, Director Ronda E. Stryker sold 201,392 shares of the firm's stock in a transaction dated Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the transaction, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. This trade represents a 5.24 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Allan C. Golston sold 2,458 shares of the firm's stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total value of $941,586.06. Following the completion of the transaction, the director now owns 14,895 shares in the company, valued at approximately $5,705,827.65. This represents a 14.16 % decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on SYK shares. Robert W. Baird upped their target price on Stryker from $378.00 to $405.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Piper Sandler reaffirmed an "overweight" rating and set a $420.00 target price (up previously from $380.00) on shares of Stryker in a research report on Wednesday, October 30th. Evercore ISI upped their target price on Stryker from $380.00 to $384.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Truist Financial upped their target price on Stryker from $409.00 to $413.00 and gave the stock a "hold" rating in a research report on Thursday, January 30th. Finally, Citigroup upped their target price on Stryker from $411.00 to $450.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, Stryker presently has a consensus rating of "Moderate Buy" and a consensus target price of $420.68.

Stryker Price Performance

Stryker stock traded down $3.82 during mid-day trading on Friday, hitting $382.59. 1,268,413 shares of the company were exchanged, compared to its average volume of 1,388,856. The company has a quick ratio of 1.32, a current ratio of 1.95 and a debt-to-equity ratio of 0.59. The business has a fifty day moving average of $378.07 and a 200 day moving average of $368.67. Stryker Co. has a 1-year low of $314.93 and a 1-year high of $406.19. The company has a market capitalization of $145.99 billion, a PE ratio of 49.30, a price-to-earnings-growth ratio of 2.93 and a beta of 0.96.

Stryker (NYSE:SYK - Get Free Report) last released its quarterly earnings data on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.87 by $0.14. Stryker had a return on equity of 23.58% and a net margin of 13.25%. During the same quarter last year, the company earned $3.46 earnings per share. As a group, sell-side analysts expect that Stryker Co. will post 13.49 earnings per share for the current year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 30th. Stockholders of record on Monday, March 31st will be paid a $0.84 dividend. The ex-dividend date is Monday, March 31st. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.88%. Stryker's dividend payout ratio (DPR) is presently 43.30%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.